HCQS
A Hydroxychloroquine brand by IPCA Laboratories — tablet, made in India.
NAFDAC registration
Our August 2026 copy of the NAFDAC Greenbook lists HCQS Tablets 200 mg — registration number 04-7590 — with status Active.
HCQS at a glance
- Generic name
- Hydroxychloroquine
- Manufacturer
- IPCA Laboratories
- Form
- Tablet
- Strength
- 200 mg
- Made in
- India
- NAFDAC reg. no.
- 04-7590
HCQS price in Nigeria
Prices for Hydroxychloroquine products vary by brand, strength, and pack size — check current prices at a licensed pharmacy, or tell us what you need and we'll connect you with a verified source.
About Hydroxychloroquine
Hydroxychloroquine is a tablet originally developed as an antimalarial, a close relative of chloroquine, that is now prescribed in Nigeria almost entirely for autoimmune disease. For a person with systemic lupus erythematosus (SLE) it is the one medicine rheumatologists want them to stay on indefinitely: it reduces flares, protects the kidneys and skin, lowers the long-term dose of steroids needed, and improves survival. It is also a standard first-line disease-modifying drug for rheumatoid arthritis. It works by damping the immune signalling that drives these diseases rather than by suppressing the immune system wholesale, which is why it is better tolerated than most alternatives and why it is on the WHO Model List of Essential Medicines.
Read the full Hydroxychloroquine guide — dosage, side effects, warnings, and all registered brands.
Frequently asked questions
Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: August 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated September 2026.